Abuse Deterrent Formulation Technology Market 2027 by Drug Class, Abuse Deterrence Approach, Product and Geography | The Insight Partners

Abuse Deterrent Formulation Technology Market Forecast to 2027 - Covid-19 Impact and Global Analysis By Drug Class (Opioids, Antidepressants, CNS Stimulants); Abuse Deterrence Approach (Physical /Chemical Barriers, Agonist / Antagonist Combinations, Aversion Approach, Prodrug Approach, Abuse-Deterrent Drug Delivery Systems); Product (Tablets, Capsules, Transdermal Patches, Thin Films, Others) and Geography

Report Code: TIPRE00016408 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Numerous different types of abuse-deterrent formulation technologies have been promoted; these comprise physical/chemical barriers that prevent drugs from being manipulated for recreational use, the addition of chemical agents that interfere with the drug's effects upon improper use abuse-resistant drug delivery/administration technologies. Abuse-deterrent formulations act as means to reduce prescription drug abuse while ensuring access to vital medications for individuals with a genuine need.

MARKET DYNAMICS

The Abuse Deterrent Formulation Technologies market is growing owing to the key factors such as rising inmisue of drugs among population, Also the use of deterrent formulations for postoperative pain. However, the regulations related to the drugs are hindering the market growth

MARKET SCOPE

The "Abuse Deterrent Formulation Technologies Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Abuse Deterrent Formulation Technologies market with detailed market segmentation drug class, abuse deterrence approach, product . The Abuse Deterrent Formulation Technologies market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Abuse Deterrent Formulation Technologies market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Abuse Deterrent Formulation Technologies market is segmented on the basis of drug class, abuse deterrence approach and product. Based on drug class, the market is segmented as opioids, antidepressants, CNS stimulants. Based on the abuse deterrence approach the market is segmented into physical /chemical barriers, agonist / antagonist combinations, aversion approach, prodrug approach, abuse-deterrent drug delivery systems. Based on product the market is segmented into tablets, capsules, transdermal patches, thin films, others

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Abuse Deterrent Formulation Technologies market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Abuse Deterrent Formulation Technologies market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Abuse Deterrent Formulation Technologies market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Abuse Deterrent Formulation Technologies market in these regions.



Get more information on this report :

MARKET PLAYERS

The report covers key developments in the Abuse Deterrent Formulation Technologies market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Abuse Deterrent Formulation Technologies market are anticipated to have lucrative growth opportunities in the future with the rising demand for Abuse Deterrent Formulation Technologies in the global market. Below mentioned is the list of few companies engaged in the Abuse Deterrent Formulation Technologies market.

The report also includes the profiles of key players in Abuse Deterrent Formulation Technologies market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Bayer
- TITAN Pharmaceuticals
- Pfizer
- Orexo
- Lonza
- Johnson & Johnson
- Acura Pharmaceuticals
- Daiichi Sankyo
- ExxPharma Therapeutics
- SunGen Pharma

Serum Institute of India The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.



Get more information on this report :

TABLE OF CONTENTS

1.   INTRODUCTION
1.1.   SCOPE OF THE STUDY
1.2.   THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3.   MARKET SEGMENTATION
1.3.1   Abuse Deterrent Formulation Technology Market - By Drug Class
1.3.2   Abuse Deterrent Formulation Technology Market - By Abuse Deterrence Approach
1.3.3   Abuse Deterrent Formulation Technology Market - By Product
1.3.4   Abuse Deterrent Formulation Technology Market - By Region
1.3.4.1   By Country

2.   KEY TAKEAWAYS

3.   RESEARCH METHODOLOGY

4.   ABUSE DETERRENT FORMULATION TECHNOLOGY MARKET LANDSCAPE
4.1.   OVERVIEW
4.2.   PEST ANALYSIS
4.2.1   North America - Pest Analysis
4.2.2   Europe - Pest Analysis
4.2.3   Asia-Pacific - Pest Analysis
4.2.4   Middle East and Africa - Pest Analysis
4.2.5   South and Central America - Pest Analysis
4.3.   EXPERT OPINIONS

5.   ABUSE DETERRENT FORMULATION TECHNOLOGY MARKET - KEY MARKET DYNAMICS
5.1.   KEY MARKET DRIVERS
5.2.   KEY MARKET RESTRAINTS
5.3.   KEY MARKET OPPORTUNITIES
5.4.   FUTURE TRENDS
5.5.   IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6.   ABUSE DETERRENT FORMULATION TECHNOLOGY MARKET - GLOBAL MARKET ANALYSIS
6.1.   ABUSE DETERRENT FORMULATION TECHNOLOGY - GLOBAL MARKET OVERVIEW
6.2.   ABUSE DETERRENT FORMULATION TECHNOLOGY - GLOBAL MARKET AND FORECAST TO 2027
6.3.   MARKET POSITIONING/MARKET SHARE

7.   ABUSE DETERRENT FORMULATION TECHNOLOGY MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1.   OVERVIEW
7.2.   DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3.   OPIOIDS
7.3.1.   Overview
7.3.2.   Opioids Market Forecast and Analysis
7.4.   ANTIDEPRESSANTS
7.4.1.   Overview
7.4.2.   Antidepressants Market Forecast and Analysis
7.5.   CNS STIMULANTS
7.5.1.   Overview
7.5.2.   CNS Stimulants Market Forecast and Analysis
8.   ABUSE DETERRENT FORMULATION TECHNOLOGY MARKET - REVENUE AND FORECASTS TO 2027 - ABUSE DETERRENCE APPROACH
8.1.   OVERVIEW
8.2.   ABUSE DETERRENCE APPROACH MARKET FORECASTS AND ANALYSIS
8.3.   PHYSICAL /CHEMICAL BARRIERS
8.3.1.   Overview
8.3.2.   Physical /Chemical Barriers Market Forecast and Analysis
8.4.   AGONIST / ANTAGONIST COMBINATIONS
8.4.1.   Overview
8.4.2.   Agonist / Antagonist Combinations Market Forecast and Analysis
8.5.   AVERSION APPROACH
8.5.1.   Overview
8.5.2.   Aversion Approach Market Forecast and Analysis
8.6.   PRODRUG APPROACH
8.6.1.   Overview
8.6.2.   Prodrug Approach Market Forecast and Analysis
8.7.   ABUSE-DETERRENT DRUG DELIVERY SYSTEMS
8.7.1.   Overview
8.7.2.   Abuse-Deterrent Drug Delivery Systems Market Forecast and Analysis
9.   ABUSE DETERRENT FORMULATION TECHNOLOGY MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
9.1.   OVERVIEW
9.2.   PRODUCT MARKET FORECASTS AND ANALYSIS
9.3.   TABLETS
9.3.1.   Overview
9.3.2.   Tablets Market Forecast and Analysis
9.4.   CAPSULES
9.4.1.   Overview
9.4.2.   Capsules Market Forecast and Analysis
9.5.   TRANSDERMAL PATCHES
9.5.1.   Overview
9.5.2.   Transdermal Patches Market Forecast and Analysis
9.6.   THIN FILMS
9.6.1.   Overview
9.6.2.   Thin Films Market Forecast and Analysis
9.7.   OTHERS
9.7.1.   Overview
9.7.2.   Others Market Forecast and Analysis

10.   ABUSE DETERRENT FORMULATION TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1.   NORTH AMERICA
10.1.1   North America Abuse Deterrent Formulation Technology Market Overview
10.1.2   North America Abuse Deterrent Formulation Technology Market Forecasts and Analysis
10.1.3   North America Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Drug Class
10.1.4   North America Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Abuse Deterrence Approach
10.1.5   North America Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Product
10.1.6   North America Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Countries
10.1.6.1   United States Abuse Deterrent Formulation Technology Market
10.1.6.1.1   United States Abuse Deterrent Formulation Technology Market by Drug Class
10.1.6.1.2   United States Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.1.6.1.3   United States Abuse Deterrent Formulation Technology Market by Product
10.1.6.2   Canada Abuse Deterrent Formulation Technology Market
10.1.6.2.1   Canada Abuse Deterrent Formulation Technology Market by Drug Class
10.1.6.2.2   Canada Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.1.6.2.3   Canada Abuse Deterrent Formulation Technology Market by Product
10.1.6.3   Mexico Abuse Deterrent Formulation Technology Market
10.1.6.3.1   Mexico Abuse Deterrent Formulation Technology Market by Drug Class
10.1.6.3.2   Mexico Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.1.6.3.3   Mexico Abuse Deterrent Formulation Technology Market by Product
10.2.   EUROPE
10.2.1   Europe Abuse Deterrent Formulation Technology Market Overview
10.2.2   Europe Abuse Deterrent Formulation Technology Market Forecasts and Analysis
10.2.3   Europe Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Drug Class
10.2.4   Europe Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Abuse Deterrence Approach
10.2.5   Europe Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Product
10.2.6   Europe Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Countries
10.2.6.1   Germany Abuse Deterrent Formulation Technology Market
10.2.6.1.1   Germany Abuse Deterrent Formulation Technology Market by Drug Class
10.2.6.1.2   Germany Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.2.6.1.3   Germany Abuse Deterrent Formulation Technology Market by Product
10.2.6.2   France Abuse Deterrent Formulation Technology Market
10.2.6.2.1   France Abuse Deterrent Formulation Technology Market by Drug Class
10.2.6.2.2   France Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.2.6.2.3   France Abuse Deterrent Formulation Technology Market by Product
10.2.6.3   Italy Abuse Deterrent Formulation Technology Market
10.2.6.3.1   Italy Abuse Deterrent Formulation Technology Market by Drug Class
10.2.6.3.2   Italy Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.2.6.3.3   Italy Abuse Deterrent Formulation Technology Market by Product
10.2.6.4   Spain Abuse Deterrent Formulation Technology Market
10.2.6.4.1   Spain Abuse Deterrent Formulation Technology Market by Drug Class
10.2.6.4.2   Spain Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.2.6.4.3   Spain Abuse Deterrent Formulation Technology Market by Product
10.2.6.5   United Kingdom Abuse Deterrent Formulation Technology Market
10.2.6.5.1   United Kingdom Abuse Deterrent Formulation Technology Market by Drug Class
10.2.6.5.2   United Kingdom Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.2.6.5.3   United Kingdom Abuse Deterrent Formulation Technology Market by Product
10.2.6.6   Rest of Europe Abuse Deterrent Formulation Technology Market
10.2.6.6.1   Rest of Europe Abuse Deterrent Formulation Technology Market by Drug Class
10.2.6.6.2   Rest of Europe Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.2.6.6.3   Rest of Europe Abuse Deterrent Formulation Technology Market by Product
10.3.   ASIA-PACIFIC
10.3.1   Asia-Pacific Abuse Deterrent Formulation Technology Market Overview
10.3.2   Asia-Pacific Abuse Deterrent Formulation Technology Market Forecasts and Analysis
10.3.3   Asia-Pacific Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Drug Class
10.3.4   Asia-Pacific Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Abuse Deterrence Approach
10.3.5   Asia-Pacific Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Product
10.3.6   Asia-Pacific Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Countries
10.3.6.1   Australia Abuse Deterrent Formulation Technology Market
10.3.6.1.1   Australia Abuse Deterrent Formulation Technology Market by Drug Class
10.3.6.1.2   Australia Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.3.6.1.3   Australia Abuse Deterrent Formulation Technology Market by Product
10.3.6.2   China Abuse Deterrent Formulation Technology Market
10.3.6.2.1   China Abuse Deterrent Formulation Technology Market by Drug Class
10.3.6.2.2   China Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.3.6.2.3   China Abuse Deterrent Formulation Technology Market by Product
10.3.6.3   India Abuse Deterrent Formulation Technology Market
10.3.6.3.1   India Abuse Deterrent Formulation Technology Market by Drug Class
10.3.6.3.2   India Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.3.6.3.3   India Abuse Deterrent Formulation Technology Market by Product
10.3.6.4   Japan Abuse Deterrent Formulation Technology Market
10.3.6.4.1   Japan Abuse Deterrent Formulation Technology Market by Drug Class
10.3.6.4.2   Japan Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.3.6.4.3   Japan Abuse Deterrent Formulation Technology Market by Product
10.3.6.5   South Korea Abuse Deterrent Formulation Technology Market
10.3.6.5.1   South Korea Abuse Deterrent Formulation Technology Market by Drug Class
10.3.6.5.2   South Korea Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.3.6.5.3   South Korea Abuse Deterrent Formulation Technology Market by Product
10.3.6.6   Rest of Asia-Pacific Abuse Deterrent Formulation Technology Market
10.3.6.6.1   Rest of Asia-Pacific Abuse Deterrent Formulation Technology Market by Drug Class
10.3.6.6.2   Rest of Asia-Pacific Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.3.6.6.3   Rest of Asia-Pacific Abuse Deterrent Formulation Technology Market by Product
10.4.   MIDDLE EAST AND AFRICA
10.4.1   Middle East and Africa Abuse Deterrent Formulation Technology Market Overview
10.4.2   Middle East and Africa Abuse Deterrent Formulation Technology Market Forecasts and Analysis
10.4.3   Middle East and Africa Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Drug Class
10.4.4   Middle East and Africa Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Abuse Deterrence Approach
10.4.5   Middle East and Africa Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Product
10.4.6   Middle East and Africa Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Countries
10.4.6.1   South Africa Abuse Deterrent Formulation Technology Market
10.4.6.1.1   South Africa Abuse Deterrent Formulation Technology Market by Drug Class
10.4.6.1.2   South Africa Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.4.6.1.3   South Africa Abuse Deterrent Formulation Technology Market by Product
10.4.6.2   Saudi Arabia Abuse Deterrent Formulation Technology Market
10.4.6.2.1   Saudi Arabia Abuse Deterrent Formulation Technology Market by Drug Class
10.4.6.2.2   Saudi Arabia Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.4.6.2.3   Saudi Arabia Abuse Deterrent Formulation Technology Market by Product
10.4.6.3   U.A.E Abuse Deterrent Formulation Technology Market
10.4.6.3.1   U.A.E Abuse Deterrent Formulation Technology Market by Drug Class
10.4.6.3.2   U.A.E Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.4.6.3.3   U.A.E Abuse Deterrent Formulation Technology Market by Product
10.4.6.4   Rest of Middle East and Africa Abuse Deterrent Formulation Technology Market
10.4.6.4.1   Rest of Middle East and Africa Abuse Deterrent Formulation Technology Market by Drug Class
10.4.6.4.2   Rest of Middle East and Africa Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.4.6.4.3   Rest of Middle East and Africa Abuse Deterrent Formulation Technology Market by Product
10.5.   SOUTH AND CENTRAL AMERICA
10.5.1   South and Central America Abuse Deterrent Formulation Technology Market Overview
10.5.2   South and Central America Abuse Deterrent Formulation Technology Market Forecasts and Analysis
10.5.3   South and Central America Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Drug Class
10.5.4   South and Central America Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Abuse Deterrence Approach
10.5.5   South and Central America Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Product
10.5.6   South and Central America Abuse Deterrent Formulation Technology Market Forecasts and Analysis - By Countries
10.5.6.1   Brazil Abuse Deterrent Formulation Technology Market
10.5.6.1.1   Brazil Abuse Deterrent Formulation Technology Market by Drug Class
10.5.6.1.2   Brazil Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.5.6.1.3   Brazil Abuse Deterrent Formulation Technology Market by Product
10.5.6.2   Argentina Abuse Deterrent Formulation Technology Market
10.5.6.2.1   Argentina Abuse Deterrent Formulation Technology Market by Drug Class
10.5.6.2.2   Argentina Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.5.6.2.3   Argentina Abuse Deterrent Formulation Technology Market by Product
10.5.6.3   Rest of South and Central America Abuse Deterrent Formulation Technology Market
10.5.6.3.1   Rest of South and Central America Abuse Deterrent Formulation Technology Market by Drug Class
10.5.6.3.2   Rest of South and Central America Abuse Deterrent Formulation Technology Market by Abuse Deterrence Approach
10.5.6.3.3   Rest of South and Central America Abuse Deterrent Formulation Technology Market by Product

11.   INDUSTRY LANDSCAPE
11.1.   MERGERS AND ACQUISITIONS
11.2.   AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3.   NEW PRODUCT LAUNCHES
11.4.   EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12.   ABUSE DETERRENT FORMULATION TECHNOLOGY MARKET, KEY COMPANY PROFILES
12.1.   BAYER
12.1.1.   Key Facts
12.1.2.   Business Description
12.1.3.   Products and Services
12.1.4.   Financial Overview
12.1.5.   SWOT Analysis
12.1.6.   Key Developments
12.2.   TITAN PHARMACEUTICALS
12.2.1.   Key Facts
12.2.2.   Business Description
12.2.3.   Products and Services
12.2.4.   Financial Overview
12.2.5.   SWOT Analysis
12.2.6.   Key Developments
12.3.   PFIZER
12.3.1.   Key Facts
12.3.2.   Business Description
12.3.3.   Products and Services
12.3.4.   Financial Overview
12.3.5.   SWOT Analysis
12.3.6.   Key Developments
12.4.   OREXO
12.4.1.   Key Facts
12.4.2.   Business Description
12.4.3.   Products and Services
12.4.4.   Financial Overview
12.4.5.   SWOT Analysis
12.4.6.   Key Developments
12.5.   LONZA
12.5.1.   Key Facts
12.5.2.   Business Description
12.5.3.   Products and Services
12.5.4.   Financial Overview
12.5.5.   SWOT Analysis
12.5.6.   Key Developments
12.6.   JOHNSON AND JOHNSON
12.6.1.   Key Facts
12.6.2.   Business Description
12.6.3.   Products and Services
12.6.4.   Financial Overview
12.6.5.   SWOT Analysis
12.6.6.   Key Developments
12.7.   ACURA PHARMACEUTICALS
12.7.1.   Key Facts
12.7.2.   Business Description
12.7.3.   Products and Services
12.7.4.   Financial Overview
12.7.5.   SWOT Analysis
12.7.6.   Key Developments
12.8.   DAIICHI SANKYO
12.8.1.   Key Facts
12.8.2.   Business Description
12.8.3.   Products and Services
12.8.4.   Financial Overview
12.8.5.   SWOT Analysis
12.8.6.   Key Developments
12.9.   EXXPHARMA THERAPEUTICS
12.9.1.   Key Facts
12.9.2.   Business Description
12.9.3.   Products and Services
12.9.4.   Financial Overview
12.9.5.   SWOT Analysis
12.9.6.   Key Developments
12.10.   SUNGEN PHARMA
12.10.1.   Key Facts
12.10.2.   Business Description
12.10.3.   Products and Services
12.10.4.   Financial Overview
12.10.5.   SWOT Analysis
12.10.6.   Key Developments

13.   APPENDIX
13.1.   ABOUT THE INSIGHT PARTNERS
13.2.   GLOSSARY OF TERMS
The List of Companies

1.Bayer
2.TITAN Pharmaceuticals
3.Pfizer
4.Orexo
5.Lonza
6.Johnson and Johnson
7.Acura Pharmaceuticals
8.Daiichi Sankyo
9.ExxPharma Therapeutics
10.SunGen Pharma
TIPRE00016408
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking